Research

Adipose Tissue Molecular Biology and Gene Regulation and Associated Disorders

Search publications

Publications

  • Villarroya-Terrade J, Cereijo R, Gavaldà-Navarro A, Peyrou M, Giralt M and Villarroya-Gombau F.

    New insights into the secretory functions of brown adipose tissue.

    J ENDOCRINOL . 243(2): . Number of citations: 122

    [doi:10.1530/JOE-19-0295]

  • Quesada T, Gavaldà-Navarro A, Morón S, Campderrós L, Iglesias R, Giralt M and Villarroya-Gombau F.

    GPR120 controls neonatal brown adipose tissue thermogenic induction.

    AM J PHYSIOL-ENDOC M . 317(5): . Number of citations: 11

    [doi:10.1152/ajpendo.00081.2019]

  • Hernáez Á, Zomeño MD, Dégano IR, Pérez-Fernández S, Goday A, Vila J, Civeira F, Moure R and Marrugat J.

    Excess Weight in Spain: Current Situation, Projections for 2030, and Estimated Direct Extra Cost for the Spanish Health System.

    REVISTA ESPANOLA DE CARDIOLOGIA . 72(11): 916-924. Number of citations: 52

    [doi:10.1016/j.rec.2018.10.010]

  • Campderrós L, Moure R, Cairo M, Gavaldà-Navarro A, Quesada T, Cereijo R, Giralt M, Villarroya-Terrade J and Villarroya-Gombau F.

    Brown Adipocytes Secrete GDF15 in Response to Thermogenic Activation.

    Obesity . 27(10): 1606-1616. Number of citations: 65

    [doi:10.1002/oby.22584]

  • Casasnovas C, Ruiz M, Schlüter A, Naudí A, Fourcade S, Veciana M, Castañer S, Albertí A, Bargalló N, Johnson M, Raymond GV, Fatemi A, Moser AB, Villarroya-Gombau F, Portero-Otín M, Artuch-Iriberri R, Pamplona R and Pujol A.

    Biomarker Identification, Safety, and Efficacy of High-Dose Antioxidants for Adrenomyeloneuropathy: a Phase II Pilot Study

    NEUROTHERAPEUTICS . 16(4): 1167-1182. Number of citations: 34

    [doi:10.1007/s13311-019-00735-2]

  • Zarei M, Pujol E, Quesada T, Villarroya-Gombau F, Barroso E, Vázquez S, Pizarro J, Palomer FX and Vazquez M.

    Oral administration of a new HRI activator as a new strategy to improve high-fat-diet-induced glucose intolerance, hepatic steatosis, and hypertriglyceridaemia through FGF21.

    BRITISH JOURNAL OF PHARMACOLOGY . 176(13): 2292-2305. Number of citations: 14

    [doi:10.1111/bph.14678]

  • Ferrer-Curriu G, Redondo-Angulo I, Guitart-Mampel M, Ruperez C, Mas-Stachurska A, Sitges M, Garrabou G, Villarroya-Gombau F, Fernández-Solà J and Planavila A.

    Fibroblast growth factor-21 protects against fibrosis in hypertensive heart disease.

    JOURNAL OF PATHOLOGY . 248(1): 30-40. Number of citations: 38

    [doi:10.1002/path.5226]

  • Cairo M, Campderrós L, Gavaldà-Navarro A, Cereijo R, Delgado-Anglés A, Quesada T, Giralt M, Villarroya-Terrade J and Villarroya-Gombau F.

    Parkin controls brown adipose tissue plasticity in response to adaptive thermogenesis.

    EMBO REP . 20(5): . Number of citations: 28

    [doi:10.15252/embr.201846832]

  • Villarroya-Terrade J, Cereijo R, Giralt M and Villarroya-Gombau F.

    Secretory Proteome of Brown Adipocytes in Response to cAMP-Mediated Thermogenic Activation.

    FRONTIERS IN PHYSIOLOGY . 10: 67-67. Number of citations: 20

    [doi:10.3389/fphys.2019.00067]

  • Malpique R, Gallego-Escuredo JM, Sebastiani G, Villarroya-Terrade J, López-Bermejo A, de Zegher F, Villarroya-Gombau F and Ibañez-Toda L.

    Brown adipose tissue in prepubertal children: associations with sex, birthweight, and metabolic profile

    INTERNATIONAL JOURNAL OF OBESITY . 43(2): 384-391. Number of citations: 24

    [doi:10.1038/s41366-018-0198-7]